• FuelPositive Corp., a growth-stage company developing a carbon-free ammonia system to address the world’s green energy needs, is preparing to roll out demonstration models of its patent-pending portable technology during the coming year
• The company’s Phase 2 Hydrogen-Ammonia Synthesizer is a means of taking air, water and sustainable electricity, and converting it into non-polluting ammonia that can generate, store, transport, and utilize hydrogen
• Hydrogen energy’s potential has been the favorite of the sustainability community, but ammonia has the capacity to outperform hydrogen thanks to its molecular composition of three hydrogen atoms bonded to a nitrogen atom
• FuelPositive’s solution not only has the capacity to generate, store, and use hydrogen through the synthesis of carbon-free ammonia, it is portable enough to allow the energy to be used wherever consumers might need it

When the Los Angeles City Council’s Energy, Climate Change, Environmental Justice and Rivers (“EECJR”) Committee approved strategies this month to move the city to 100 percent carbon-free energy by 2035 with a supportive workforce, it joined a handful of government entities throughout North America driven to advance complete clean energy solutions but also raised questions about how to precisely define “carbon-free” (https://ibn.fm/Hr6zM). Internet behemoth Google raised a similar question after achieving a carbon-neutral posture in 2007, striving to improve on its efforts to decarbonize its electricity supply completely and “operate on 24/7 carbon-free energy, everywhere, by 2030” (https://ibn.fm/wxoaL). For years, industry leaders and consumers have increasingly called for less expensive fuels and greater responsiveness to the planet’s pollution crises. Clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is helping to nudge that movement forward by developing a patent-pending first-of-its-kind technology for creating carbon-free ammonia (“NH3”). Ammonia production is a multi-billion-dollar industry that supplies large-scale agricultural needs to help keep food on consumers’ tables. But it also has been a carbon-intense process, which puts it in the company of other global industries that meet worldwide consumer needs while generating significant pollution that affects conditions for the planet everyone lives on. Ammonia is also known as hydrogen nitride (“NH3”) because it consists of one nitrogen atom bonded to three hydrogen atoms. It therefore has an energy density nearly double that of liquid hydrogen by volume, and hydrogen is of course already a highly sought-after component of popular solutions for green energy fuel. So ammonia has the potential to transform from a polluting product to one that outstrips hydrogen as a green fuel source (https://ibn.fm/LKUm8). FuelPositive’s Phase 2 Hydrogen-Ammonia Synthesizer commercial prototype systems are part of the company’s mission to foster licensing, partnership and acquisition opportunities that build on energy-efficient technologies. It also has the potential to become a viable alternative to fossil fuels. FuelPositive’s product takes air, water and sustainable electricity and converts it into non-polluting ammonia that can generate, store, transport and utilize hydrogen in an economical and quick-output manner. Easier to distribute than liquid hydrogen, the Phase 2 Hydrogen-Ammonia Synthesizer system is portable and scalable with the ability to enable end users make clean NH3 and generate green energy wherever they might see a need. FuelPositive has partnered with National Compressed Air Canada Ltd. in order to roll out the first demonstration models of the system early next year (https://ibn.fm/LTVLt). A recent study published by Market Study Report LLC reports that the market for green ammonia is predicted to grow at a CAGR of 54 percent between 2020 and 2025, propelled by concerns about the effect of fossil fuel emissions on the climate globally (https://ibn.fm/JzweU). But FuelPositive’s technology could lead the market to exceed expectations. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• China crackdown on mining of cryptocurrencies opens opportunity for U.S. market to explode
• PRPI building efficient, powerful network of cryptocurrency mining operations that offers environmentally friendly solutions for sustainability of the blockchain industry
• Revolutionary GEM system optimizes the collection of green energy such as solar, wind and hydro

While China is cracking down on the mining of cryptocurrencies over concerns about environmental impact, savvy companies in the United States, including Perpetual Industries (OTC: PRPI), are looking to benefit. A recent Forbes articles reports that mining is about to get both easier and more profitable for North American crypto miners (https://ibn.fm/RZHat). “Until recently, China accounted for between 65% and 75% of all Bitcoin mining,” stated Forbes. “Market dominance is expected to shift to North America, though, after an estimated 90% of China’s Bitcoin mining capacity has been ordered to shut down due to concerns over its environmental impact. . . . This could be highly favorable for U.S. and Canadian crypto miners . . . who (for now) will no longer have to compete with China for precious blocks.” An incubator for the development of new and innovative energy-efficient technologies, Perpetual Industries has been working on building an efficient, powerful network of cryptocurrency mining operations that offer environmentally friendly solutions for the sustainability of the blockchain industry (https://ibn.fm/26yxI). “Our goal is to advance and integrate green energy power sources such as solar, wind, and hydro in order to lessen the environmental impact of decentralized blockchain systems,” the company states, noting that current research and development efforts are underway for the creation of a proprietary system. “We are researching a new, revolutionary design for a crypto-mining farm system that optimizes the collection of green energy to produce a powerful, self-sustaining mining farm called the Green Energy Mining (‘GEM’) System.” The innovative GEM approach will incorporate masternodes, proof of stake, proof of work and Dapps all in one system. “We hope to significantly reduce the cost of power consumed by miners in the fast-emerging global blockchain and crypto-mining industry,” stated the company, which is applying its expertise and knowledge of low-cost, green-energy-powered solutions to the development of blockchain mining operations. Perpetual Industries is an incubator for the development of new and innovative energy-efficient technologies. The company’s mission is to “perpetuate industry” by bringing value-added technologies to market. The company is expanding its expertise and knowledge of energy-efficient technology by developing low-cost, green-energy-powered solutions for a variety of industries while continuing its research, development and commercialization of the XYO Technology in key applications. For more information, visit the company’s website at www.PerpetualIndustries.com. NOTE TO INVESTORS: The latest news and updates relating to PRPI are available in the company’s newsroom at https://ibn.fm/PRPI

• Four largest hearing aid manufacturers currently control 84% of the market, according to Biden administration
• Biden signed an executive order directing the U.S. Department of Health and Human Services to consider OTC hearing aid sales
• InnerScope Hearing Technologies aims to disrupt the market through online sales of Direct-to-Consumer Bluetooth-powered self-adjusting rechargeable hearing aids
• InnerScope’s launches its hearing aids on FSAstore.com, HSAstore.com, and WellDeservedHealth.com consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs
• Company recently announced a six-month campaign across major networks, including Fox News, Fox Business Network, CNN, CNBC, Newsmax TV, MSNBC, Bloomberg

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently launched a massive awareness campaign aimed at nearly 48 million Americans currently suffering from hearing loss (https://ibn.fm/ar3Mc). The campaign was in direct response to moves recently made by the Biden administration to liberalize the hearing aid market, part of a sweeping executive order signed by the president recently that proposed rules to allow hearing aid sales over the counter (https://ibn.fm/cSoed). “A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary,” reads the executive order summary. “Rather, this requirement serves only as red tape, and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market”. According to a White House Fact Sheet detailing the executive order, hearing aids can cost up to $5,000 per pair, putting them out of reach of millions of hearing-impaired Americans. InnerScope is positioned strongly to capture this demand increase with the company’s Bluetooth-powered self-adjusting rechargeable hearing aids currently available at its dedicated online store. “InnerScope’s hearing aids work with any smartphone, require no medical evaluation or professional help, and deliver the same personalized hearing quality and satisfaction as hearing aids sold by hearing care professionals,” said InnerScope Hearing Technologies’ CEO Matthew Moore. InnerScope recently launched its hearing aids and related hearing products on FSAstore.com, HSAstore.com, and WellDeservedHealth.com for the 70 million consumers enrolled in flexible spending accounts (“FSA”), health saving accounts (“HSA”), and employers’ health incentive programs.  InnerScope partnered with the online retailer and industry leader in the U.S. tax-free healthcare market. Moreover, InnerScope’s hearing aids and related hearing products qualify as eligible products for FSA and HSA users and is the only company on the retailers’ websites to offer hearing aids. InnerScope’s marketing efforts to spur sales include a six-month “Media Blitz” campaign recently announce to increase hearing loss awareness and drive traffic to its website. Over the six-month period, the campaign will include 156 digital billboards running three times per hour throughout lower Manhattan in New York City and televised commercials on major networks, including Bloomberg, Fox News, Fox Business Network, CNBC, Newsmax TV, CNN, and MSNBC. “The launch of our Hearing Loss Media Blitz Campaign could not have come at a better time, especially after last week’s executive order from President Biden,” said Moore, “and his remarks on making hearing aids more affordable and able to be sold over the counter in pharmacies without any medical evaluation,” InnerScope Hearing Technologies is dedicated to improving the quality of life for over 70 million North Americans and 1.5 billion people worldwide that suffer from hearing impairment and hearing-related issues. The company produces, distributes, and markets direct-to-consumer FDA-registered Bluetooth app-controlled hearing aids, Bluetooth app-controlled personal sound amplifier products, and hearing-related treatment therapies that include doctor-formulated hearing and tinnitus dietary supplements. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• The expansion into social media platforms SNAP, Facebook, and Instagram has increased customer access worldwide
• NexTech’s 3D ads are in a position to leverage the $1.98 billion AR ad placement segment of the $6.87 mobile AR market
• Company pursuing a total of four unique verticals – Virtual Conference Platform, ARitize(TM) for eCommerce, ARitize(TM) 3D/AR Advertising Platform, and the future ARitize(TM) Hollywood Studios
• NexTech leverages its proprietary platforms to procure and expand partnerships with numerous blue-chip customers. Current customer base includes Amazon, Johnson & Johnson, ViacomCBS, Toyota, and Carnegie Mellon University

NexTech AR Solutions (CSE: NTAR) (OTCQB: NEXCF), a Toronto-based leader in the rapidly growing augmented reality (“AR”) industry, has gone live with enhanced 3D Google Ad functionality through the launch of WebXR. NexTech customers can now tap into Google’s vast network and deliver 3D ads that are streamlined and engaging and do not require application download. This upgrade leverages WebXR and also allows for an AR experience with each ad (https://ibn.fm/i9xVX). NexTech ads provide rich and robust analytics, giving customers access to better data-driven insight to capture impressions, clicks, interactions, and gain an overall picture of AR engagement data. “Digital consumers are looking for engaging immersive experiences. The combination of NexTech AR’s 3D model creation at scale with NexTech’s Ad Network now on Google Ads creates an incredibly valuable offering that accelerates our customer’s reach with higher engagement levels,” NexTech CEO Evan Gappelberg said. “The Google Display Network reaches 90 percent of internet users worldwide, across millions of websites, news pages, blogs, and Google sites like Gmail and YouTube.” In addition to the enhanced Google Ad functionality, NexTech announced that it has advanced into the next generation of Ad technology by integrating with social media platforms (SNAP, Facebook, Instagram) and broadening the company’s 3D/AR ad reach. Each of these platforms brings a unique and diverse viewing audience for NexTech’s 3D ads due to the high numbers of daily active users on each platform – 293 million on SNAP, 1.9 billion on Facebook, and 500 million on Instagram. The most recent integration has now increased NexTech’s customer access across users worldwide (https://ibn.fm/1kMzb). NexTech’s complete end-to-end AR platform was designed to help businesses increase online sales. Alongside ARitize(TM) 3D/AR Advertising Platform, the company also offers:

• Virtual Conference Platform: an advanced AR and video learning system platform for events that leverages a SaaS model that gives an organization the ability to create engaging virtual event management
• ARitize(TM) for eCommerce: launched in 2019, the SaaS platform for webAR serves as a full-funnel end-to-end eCommerce solution for the AR industry and utilizes the proprietary ARitize 360 App for 3D product capture
• ARitize(TM) Hollywood Studios: currently in development; a means of producing immersive content using 360-degree videos and AR as a primary display platform

The company’s goal is to leverage these platforms to procure and expand partnerships with numerous blue-chip customers. The current customer base includes Amazon (NASDAQ: AMZN), Johnson & Johnson (NYSE: JNJ), ViacomCBS (NASDAQ: VIAC), Toyota (NYSE: TM), and Carnegie Mellon University. With its proprietary platforms, NexTech is uniquely positioned to tap into growth opportunities available on the expanding mobile AR market. According to ARtillery Intelligence’s Mobile AR Global Revenue Forecast 2020-2025, the annual reported revenue for mobile AR was $6.87 billion in 2020. This amount is expected to grow at a CAGR of 30.5%, resulting in a revenue total of $26.05 billion in 2025. NexTech has the potential to disrupt the $1.98 billion AR ad placement segment of this market, which is the second-highest category after enterprise productivity and before consumer in-app purchases (https://ibn.fm/2IF2N). For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Canadian clinical-stage drug development company InMed Pharmaceuticals is working to achieve pharmaceutical approval of rare cannabinoids
• InMed Pharmaceutical has developed a trademarked platform called IntegraSyn that extracts five times the normally expected yields of cannabinoids from its plant sources
• IntegraSyn’s ability to increase yields may ultimately help InMed to achieve a profitable means of producing cannabinol (“CBN”) and other lesser-known cannabinoids at commercial scales
• To date, GW Pharma’s Epidiolex is the only cannabis-derived product to achieve FDA approval as a pharmaceutical, and the company’s multi-million-dollar revenues demonstrate the potential returns a pharmaceutical-level drug can achieve

British Columbia, Canada-based InMed Pharmaceuticals (NASDAQ: INM) is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn with a goal of advancing its rare and lesser-known cannabinoid production to commercial levels. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn(TM) process into larger vessels,” InMed Pharmaceuticals CEO Eric A. Adams stated in a recent Vista Partners interview (https://ibn.fm/2fQhd). “Considering our production methodology is being designed with the flexibility to produce multiple cannabinoids, it opens up many different markets and consumer categories,” Adams added. “We continue to develop relationships with contract manufacturing organizations for scale-up of the process with the anticipation of commercializing the process shortly. Our immediate commercial plans are to become a B2B wholesale supplier of rare cannabinoids to companies that are seeking to integrate rare cannabinoids into their marketed products.” IntegraSyn targets the manufacture of pharmaceutical-grade cannabinoids rather than the market for recreational use products, which includes an effort to create a commercial pipeline for cannabinoid-based medications that target diseases with high unmet medical needs. The company’s initial focus is on the therapeutic benefits of cannabinol (“CBN”), a mildly psychoactive cannabis component derived from tetrahydrocannabinolic acid (“THC-A”) that can be used to relieve pain and inflammation stemming from conditions such as arthritis and Crohn’s disease (https://ibn.fm/kRNZ0). “Beyond the well-known cannabinoids of THC and CBD, there’s a whole world of rare cannabinoids including CBG, CBN, CBC and THCV with unique properties that are believed to have a wide range of health benefits. These minor or rare cannabinoids are present in much smaller quantities in the plant and therefore have not been studied extensively due to limited access,” Adams stated. “Achieving a (high) yield of 5g/L (with IntegraSyn) means we were able to make 5 times more cannabinoid product using the same process in the same amount of time, thus substantially lowering overall manufacturing costs. Achieving a yield of 5g/L significantly exceeds any currently reported industry yields, making InMed one of the leaders within the industry.” InMed Pharmaceuticals anticipates further increasing the cannabinoid yield as achieved with IntegraSyn and supplying companies that intend to market finished products with economies of scale that further reduce overall manufacturing costs. By their nature, pharmaceutical-grade products are the most expensive because of the greater efforts required to establish production process controls, validate the production system and ultimately offer final assurances of the product’s sustained quality. At this time, only one cannabis-based product has achieved FDA approval — GW Pharma’s Epidiolex was developed in 2018 as a pharmaceutical-grade oral solution containing cannabidiol (“CBD”) for the treatment of seizures associated with two rare and severe forms of epilepsy (https://ibn.fm/7Y2Ha) and last year treatment of a third disease was added to the drug’s indicated effectiveness (https://ibn.fm/YxERW). Adams noted that GW Pharma was recently acquired by Jazz Pharmaceuticals (NASDAQ: JAZZ) for $7.2 billion and that the company’s sales exceeded $500 million during 2020 and were expected to grow to over $1 billion soon. “What this tells us is, if you can advance one of these rare cannabinoids through the pharmaceutical development process, which is both lengthy and costly, and demonstrate both clinical efficacy and relative safety in a certain disease, it presents a significant commercial opportunity,” he said. For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• Red White & Bloom Inc. recently completed the acquisition of an operational 45,000 square-foot greenhouse situated on 4.7 acres of land in Apopka, Florida
• The acquisition comes less than four months after the company closed the purchase of a property in Sanderson, Florida
• RWB is intent on expanding its cultivation footprint in Florida as it also seeks to grow the number of retail stores in the state
• The Apopka facility will add near term cultivation capacity as RWB waits for the Sanderson facility to become operational

A little less than four months after completing the acquisition of a property in Sanderson, Florida, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a company leveraging brand acquisitions and partnerships to become one of the top three multi-state operators in the US legal cannabis and hemp market, has completed another acquisition as part of efforts to expand its cultivation footprint in Florida. Announced August 4, the acquisition, completed for a total purchase price of US$1,887,000 payable in cash (on closing and in 5 monthly instalments commencing 30 days after closing) and RWB common shares, includes an operational 45,000 square-foot greenhouse sited on 4.7 acres of land in Apopka, Florida (https://ibn.fm/9cFlY). RWB intends to begin rapid development on the newly acquired facility to ensure all compliance standards are met in time for a Q4 2021 harvest. The Apopka facility will add near term cultivation capacity as RWB waits for its Sanderson facility to become operational. To bring the Sanderson facility online, the company announced on April 6 that it had secured 30 double-wide, fully enclosed cultivation pods that collectively provide about 19,000 square feet of operating space. The pods will be deployed at the Sanderson property, which covers over 15 acres of land and has a 113,546 square-foot facility for cultivation and processing (https://ibn.fm/4VZvH). “The Apopka facility is part of the overall strategic vision RWB has for Florida, and we are excited to see such forward progress being made since acquiring our license earlier this year,” stated Jim Frazier, GM of RWB Florida. “The Apopka acquisition cements the fact that we are committed to expansion in Florida, which is in line with the overall company’s growth strategy across the country.” The two acquisitions are part of a two-pronged strategy that also entails opening new retail stores during the second half of 2021. In line with this target, RWB is building a consistent retail footprint and product line to align with Florida’s medical market. The company also expects to brand its Florida medical dispensaries beginning in the fourth quarter of 2021. According to Red White & Bloom CEO Brad Rogers, the Apopka facility will allow the company to serve patients with the quality and consistency they deserve in addition to delivering the cultivation required to meet its significant retail expansion goals throughout Florida. Notably, RWB has always considered Florida a priority market as it seeks to implement its core strategy – to focus on a limited number of markets within which to operate at scale. With the acquisition of the Sanderson property having already marked RWB’s path to entry into the third-largest market by revenue in the US (https://ibn.fm/dzET4), the new Apopka purchase cements this entry and expansion in the state. In a 2020 report, analysts at Arcview Market Research and BDSA observed that as the US legal cannabis market grows at an 18.2% CAGR to reach $33.9 billion in 2025, Florida will be among the top contributors to this growth (https://ibn.fm/o5bJG). Presently, Florida’s legal cannabis market is estimated to be worth $1.2 billion, with observers pointing out that it is growing every day (https://ibn.fm/LYm6C). In addition to enabling the company to tap into this growth by furthering its expansion in the state, the Apopka facility will facilitate RWB’s product selection plan for its branded dispensaries, as well as provide 40-50 additional employment opportunities for the local community when fully online. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• A new study reveals that an estimated 2.5 billion tons of food goes uneaten around the world each year
• Producing food uses a huge amount of land, water and energy, so wasted food significantly impacts climate change”
• Save Foods is committed to address two major global issues: food waste and loss, and food safety

An estimated 2.5 billion tons of food goes uneaten worldwide each year, according to the latest study done by World Wildlife Fund (“WWF”) and U.K. retailer Tesco Plc. (https://ibn.fm/vfC5U). That is an astonishing 1.2 billion tons more than previously reported, making the work done by Save Foods (NASDAQ: SVFD), an agri-food tech company focused on creating solutions to food waste and loss as well as food safety, even more urgent. “Today, WWF and Tesco publish ‘Driven to Waste,’ a new report that quantifies the total amount of food lost on farms globally, revealing an estimated 2.5 billion tonnes of food goes uneaten around the world each year,” WWF reported. “That is an increase of approximately 1.2 billion tonnes on the established estimates of 1.3 billion tonnes wasted each year. These new estimates indicate that of all the food grown, approximately 40 percent goes uneaten, which is higher than the previously estimated figure of 33%.” WWF noted that the information in its report, when combined with updated data on loss in supply chains and waste at retail and consumption, provides “a clearer picture of the scale of food loss and waste from farm to fork.” The organization also noted that “producing food uses a huge amount of land, water and energy, so wasted food significantly impacts climate change — previous estimates suggest that food waste accounts for 8% of greenhouse gases (“GHG”). Driven to Waste’s new data indicate that the numbers are even more substantial, pointing to a contribution of approximately 10% of all GHG emissions. This is the equivalent of nearly twice the annual emissions produced by all the cars driven in the U.S. and Europe. Save Foods is committed to address two major global issues: food waste and loss, and food safety. In addition to the astronomical numbers of food wasted, Save Foods points out that almost 1 in 10 people fall ill every year from eating contaminated food, costing us around $90 billion.” On top of that, the world’s population is forecast to grow to almost 10 billion people by 2050, boosting agricultural demand by some 50%,” the company notes. “Providing healthy and safe food to feed the world’s population is one of the biggest challenges of the 21st century.” At face value, the implications of food waste are immense, with one recent report noting that “the amount of food waste in America alone is simply mind numbing, weighing in at 133 billion pounds and $161 billion worth of food in 2010. That means 31% of all food produced annually is wasted. As a subcategory, 644 million tons of fruit and vegetables, or 42% of total supply, is wasted annually” (https://ibn.fm/KieJo). Save Foods offers the first green product with potential to actually replace the different residuals chemicals used today while also addressing the challenges of both food waste and food safety. The company’s core applications are ecofriendly, post-harvest treatments for fruits and vegetables. SVFD’s proprietary technologies reduce the need for conventional post-harvest fungicide by at least 50% — even entirely in some cases — can reduce food loss due to spoilage by up to 50% on average. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and the consumers alike. For more information, visit the company’s website at www.SaveFoods.co. NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. Attendees will discover the various areas that blockchain technology can be used in including clinical research and drug development. The pandemic highlighted the importance of leveraging blockchain technology for overcoming hurdles in the supply chain system. Some accomplished blockchain consultants and professionals will be sharing their opinions, keynotes and addressing the attendees about how blockchain technology can be applied to the life science industry. These blockchain industry stalwarts will guide the participants on how to unlock the full potential of this technology, assess the risks and the challenges, and guide them in developing a curated roadmap for their organization. Blockchain technology provides a viable digital solution that is more important than ever in the COVID pandemic era and aids in seamless monitoring within the vaccine supply chain. Blockchain technology assists in environmental monitoring during transport, storage, and provides visibility throughout the chain of custody. Some instances in the biopharma and medical devices suggest the benefits of blockchain solutions in providing transparency, traceability, and efficiency. The changing scenario has given rise to the need for investigating the challenges in advancing the use of this technology from proof of concept to full-scale implementation. Top reasons to attend the conference:

• Real-time uses of blockchain to improve supply-chain efficiency
• New policies and details that help in preventing counterfeiting
• New ways to ensure trust and transparency in the clinical trials
• Learn and understand from case studies presented by the speakers
• Interact and access networking opportunities with eminent industry stalwarts and thinkers

To make blockchain technology a success, all authority associations must join hands to strengthen the management system for novel digital solutions. To know more or attend the conference, please visit https://ibn.fm/JIew4

• Monazite sand is so valuable because of its superior distributions of magnetic REEs for use in clean-energy, defense and other technologies
• UUUU has licenses, ability to unlock the value of this domestic resource
• This year, the company and its partners have created a U.S.-E.U. rare earth supply chain

Monazite has long been recognized as one of the most valuable rare earth elements (“REEs”) in the world, but it requires specific licenses and specialized technical capabilities to handle and process. Energy Fuels (NYSE American: UUUU) (TSX: EFR) may be the only company outside of China with the equipment, expertise and licenses in place to responsibly process this importance mineral for the recovery of rare earths at the highest standards of environmental sustainability. “Monazite sand is so valuable because of its superior distributions of magnetic REEs needed for various clean energy, defense and other advanced technologies,” a recent Energy Fuels article states (https://ibn.fm/nPZk4). “Natural monazite sand is currently recovered as a low-cost byproduct of heavy mineral sand operations in the U.S. and elsewhere in the world. “The historic challenge with monazite is that it contains higher concentrations of natural uranium, thorium and other radionuclides relative to other minerals, thereby requiring specific licenses and specialized technical capabilities to handle and process,” the article continued. “Energy Fuels currently holds the required licenses, and we have developed the ability to unlock the value of this domestic resource over the past 20+ years of recycling numerous feeds for the recovery of uranium. Energy Fuels’ commercial-scale production of RE carbonate from U.S.-mined natural monazite sand positions Energy Fuels as the only company in North America currently producing a monazite-derived, enhanced rare earth material.” Prior to Energy Fuels’ involvement in processing this valuable REE-bearing mineral, all monazite was sold to China, which dominates every aspect of global rare earth markets, from mining to processing to manufacturing. “China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world. Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs” (https://ibn.fm/VLyfr). Energy Fuels involvement in this effort is essential. The company, along with key partners, is focused on establishing the United States again as a producer of advanced rare earth products, all produced from monazite, with a commitment to sustainability, environmental protection and human rights. The company is also creating a supply chain option that allows monazite suppliers in the U.S. and around the world to participate in the profits from downstream rare earth processing and production of advanced materials, including separated oxides, metals and alloys, and perhaps even permanent REE magnets needed for EVs, advanced technologies and renewable energy. “What I find most exciting about all this is that not only do we have excellent optionality and exposure to improved uranium markets, we are also leveraging our existing uranium assets to give the company and our shareholders exposure to vanadium, REEs and potentially medical isotope markets, all as complements to our primary uranium business,” said Energy Fuels president and CEO Mark S. Chalmers. “Each of these complementary businesses could develop into a significant business for the company in its own right and bodes well for our quickly developing ‘Critical Minerals Hub’ in the U.S.” Energy Fuels is the leading uranium producer in the United States; the company also produces vanadium from certain of its projects, and it was the nation’s largest producer of this critical mineral in 2019. Vanadium is used in steel, master alloys and emerging utility-scale batteries, with prices up over 80% this year. Headquartered in Denver, Colorado, UUUU holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• AmpliTech’s commitment to quality and performance is paying off, as seen through two of its recent announcements
• The company reported it had secured a follow-on order for its LNA technology from a long-standing Fortune 500 customer
• It also announced inclusion in the Russell Microcap Index that brings together 2,000 companies, whose membership depends on the market capitalization and style attributes

As a company that designs, develops, and manufactures radio frequency (“RF”) components (amplifiers) for satellite and 5G communication, defense, quantum computing, and space markets, AmpliTech Group (NASDAQ: AMPG) has built a reputation anchored on quality and performance that has earned it recognition and business in equal measure. Two recent announcements, made in late June, perfectly illustrate this dual nature of AMPG’s successes. On June 24, AmpliTech reported it had secured a follow-on order for its low noise amplifier (“LNA”) technology from a long-standing Fortune 500 global defense and aerospace customer, with the products expected to ship in the third quarter of fiscal 2021 (https://ibn.fm/8qpBA). AMPG Founder-CEO Fawad Maqbool hailed the order as a demonstration that the performance, quality, and return on investment of the company’s solutions were continuing to earn repeat business from global leaders. “We are ramping up our product development and sales and marketing efforts to position AmpliTech to supply cutting edge technologies for the built-out of satellite, 5G/6G communications, and other specialty applications that require high-quality signal processing solutions,” added Maqbool. Maqbool also noted that as the economy reopens, the company’s target customers and industries are returning to more normal business and procurement patterns, creating an expanding range of revenue opportunities. Also, with its existing resources, including about $30 million in net cash raised following a recapitalization over the first four months of 2021, the company is well positioned to actively pursue aggressive growth plans and opportunities. AmpliTech’s focus on developing quality and state-of-the-art signal-processing components, progress thus far, and commitment to growth have not gone unnoticed. The company was recently added to the Russell Microcap Index together with the Index’s annual reconstitution, effective June 25 (https://ibn.fm/TdX4J). A part of the FTSE Russell – a global index leader providing innovative benchmarking, analytics, and data solutions for investors worldwide – the Russell Microcap Index provides a comprehensive, unbiased measurement for the microcap segment of the US equity market. Membership in the Russell Microcap Index, which brings together 2,000 companies, is determined mainly by objective market-capitalization rankings and style attributes and remains in place for one year. “Inclusion in the Russell Microcap Index is a testament to the progress we have made positioning AmpliTech to participate in the build-out of satellite networks, 5G communications, and other next-generation networks,” stated Maqbool. “We are actively pursuing the broad range of growth opportunities before us… We expect AmpliTech’s exciting outlook to be supported by the added investment community visibility and awareness provided by our Russell Index inclusion.” AmpliTech is focused on being a reliable supplier for high-quality amplifiers needed in telemetric applications, wherein optimal performance is pivotal for successful deployment. It is also keen on supplying components that support systems, which offer enhanced data and bandwidth capabilities vital for undergirding rapid growth in connected devices, entertainment and gaming distribution, video conferencing, Internet of Things (‘IoT”) applications, autonomous-vehicle communications, quantum computing, space exploration, and other bandwidth-intensive applications. For more information, visit the company’s website at www.AmpliTechInc.com. NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at https://ibn.fm/AMPG